A. Barta

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

E Kelemen, Tamás Masszi, Péter Reményi et al. · Bone Marrow Transplantation · 1998 · 33 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Non-myeloablative Drug Combination +12

Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia

László Gopcsa, A. Barta, A Bányai et al. · Bone Marrow Transplantation · 2002 · 23 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12

Changes of salivary amylase in serum and parotid gland during pharmacological and physiological stimulation

Ákos Nagy, A. Barta, Gábor Varga et al. · Journal of Physiology-Paris · 2001 · 21 citations

Physiological Stimulation, Salivary Amylase, Medicine +5

The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Katalin Balassa, Hajnalka Andrikovics, Péter Reményi et al. · Bone Marrow Transplantation · 2015 · 21 citations

Cell Therapy, Transplantation, Marrow Transplantation +13

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years

Péter Reményi, Gergely Varga, Gábor Mikala et al. · Transplantation Proceedings · 2016 · 20 citations

Hematological Malignancy, Radiation Oncology, Cell Therapy +13